Roche Buys Bioimagene for $100 Million, Boosts Diagnostics

24.08.2010 - Swiss drugmaker Roche Holding is buying U.S. - based Bioimagene for some $100 million, making another bolt-on acquisition to cement its dominant position in tissue-based cancer...